Y. Ionova

Analyzing excipient-related adverse events in antiseizure drug formulations

Y. Ionova, Thomas Peterson, Leslie Wilson, 2022, Epilepsy Research.

Biologic excipients: Importance of clinical awareness of inactive ingredients

Y. Ionova, Leslie Wilson, 2020, PloS one.

Cost-Effectiveness Analysis of Atezolizumab Versus Durvalumab as First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer in the USA

L. Zhong, Y. Ionova, Leslie Wilson, 2022, Clinical Drug Investigation.

Preferences for Risks and Benefits of Islet Cell Transplantation for Persons With Type 1 Diabetes With History of Episodes of Severe Hypoglycemia: A Discrete-Choice Experiment to Inform Regulatory Decisions

S. Gitelman, T. Irony, M. Ho, 2022, Transplantation.

CYP2C19 Allele Frequencies in Over 2.2 Million Direct‐to‐Consumer Genetics Research Participants and the Potential Implication for Prescriptions in a Large Health System

James R. Ashenhurst, B. Tamraz, H. Nhan, 2020, Clinical and translational science.

CAPER: Patient Preferences to Inform Non-Surgical Treatment of Chronic Low Back Pain (cLBP): A Discrete Choice Experiment.

W. Mehling, J. Lotz, J. Hanmer, 2023, Pain medicine.